Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Allergan plc    AGN   IE00BY9D5467

ALLERGAN PLC

(AGN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/18/2020 02/19/2020 02/20/2020 02/21/2020 02/24/2020 Date
198(c) 198.81(c) 198.74(c) 200.15(c) 198.17(c) Last
1 737 510 2 238 397 1 840 157 2 710 542 3 326 792 Volume
-0.16% +0.41% -0.04% +0.71% -0.99% Change
More quotes
Financials (USD)
Sales 2020 16 016 M
EBIT 2020 7 275 M
Net income 2020 192 M
Debt 2020 12 217 M
Yield 2020 1,51%
Sales 2021 16 292 M
EBIT 2021 7 487 M
Net income 2021 1 691 M
Debt 2021 7 857 M
Yield 2021 1,59%
P/E ratio 2020 132x
P/E ratio 2021 36,7x
EV / Sales2020 4,83x
EV / Sales2021 4,48x
Capitalization 65 198 M
More Financials
Company
Allergan plc is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter pharmaceutical products. The Company operates through three segments:... 
Sector
Pharmaceuticals
Calendar
05/12Earnings Release
More about the company
Surperformance© ratings of Allergan plc
Trading Rating : Investor Rating :
More Ratings
Latest news on ALLERGAN PLC
02/24DAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
02/24ALLERGAN : Form 8.3 -
DJ
02/21DAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
02/21ALLERGAN : Form 8.3 -
DJ
02/20DAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
02/20ALLERGAN : Form 8.3 - Allergan Plc
DJ
02/19ALLERGAN : Beth Fegan of FeganScott Law Firm Named Co-Lead Counsel in Allergan B..
BU
02/19DAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
02/19DAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan PLC
AQ
02/19ALLERGAN : Form 8.3 - Allergan Plc
DJ
02/18ALLERGAN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
02/18ALLERGAN : Form 8.3 -
DJ
02/17ALLERGAN : Announcement under the Irish Takeover Rules Relevant Securities in Is..
AQ
02/17ALLERGAN : Form 8.3 -
DJ
02/17ABBVIE : Form 8.3 -
DJ
More news
News in other languages on ALLERGAN PLC
02/13ALLERGAN PLC : Ex-dividend day for
02/12Teva de nouveau dans le rouge en 2019, prévisions prudentes pour 2020
02/12AUSBLICK NESTLÉ : Organisches Wachstum von 3,6 Prozent erwartet
02/12TEVA : perte nette de presque 1 milliard de dollars en 2019
02/10Aktien New York Ausblick: US-Börse nach Gewinnmitnahmen zunächst auf Standby
More news
Analyst Recommendations on ALLERGAN PLC
More recommendations
Sector news : Pharmaceuticals - NEC
02/24J&J, Sanofi, Inovio Hunt for Coronavirus Vaccines
DJ
02/24Grain Futures Fall as Coronavirus Spreads
DJ
02/24NOVARTIS : FDA, EMA Accept Filings for Ofatumumab in Relapsing Multiple Sclerosi..
DJ
02/24LONZA : France's Sanofi to carve out active drug ingredients business
RE
02/24SANOFI : to Create Pharmaceutical Ingredients Leader With Eyes to Spinoff
DJ
More sector news : Pharmaceuticals - NEC
Chart ALLERGAN PLC
Duration : Period :
Allergan plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ALLERGAN PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Average target price 197,00  $
Last Close Price 198,17  $
Spread / Highest target 28,7%
Spread / Average Target -0,59%
Spread / Lowest Target -20,8%
EPS Revisions
Managers
NameTitle
Brenton L. Saunders Chairman, President & Chief Executive Officer
Wayne R. Swanton Executive Vice President-Global Operations
Matthew M. Walsh Chief Financial Officer & Executive Vice President
C. David Nicholson Chief Research & Development Officer & EVP
Charles Hugh-Jones Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN PLC4.70%65 850
JOHNSON & JOHNSON2.78%395 024
ROCHE HOLDING AG10.13%300 195
NOVARTIS2.72%218 568
MERCK AND COMPANY-9.47%209 636
PFIZER-8.83%197 679